Universal Registration Document Including Annual Financial Report

Overview

The report describes CARMAT's 2019 progress in clinical development, production, financing, and organizational expansion. The company implanted the twelfth pivotal-study patient, reported that 73% of patients achieved the six-month primary objective, and obtained FDA authorization to begin a 10-patient US feasibility study. It also completed the production transfer to Bois d'Arcy, raised EUR60 million, and ended the year with 107 employees. Environmental disclosures address chemical and biological risks, prevention measures, and outsourced waste management.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2019
Period: 1 January 2019 – 31 December 2019
Publication date: 13 March 2020
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services